CI
EW icon

Clal Insurance’s Edwards Lifesciences EW Stock Holding History

Clal Insurance’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-9,000
Closed -$831K – 126
2024
Q2 		$831K Buy
+9,000
New +$797K 0.01% 98
2023
Q4 		– Sell
-5,000
Closed -$346K – 130
2023
Q3 		$346K Buy
+5,000
New +$402K ﹤0.01% 110
2023
Q1 		– Sell
-15,500
Closed -$1.16M – 151
2022
Q4 		$1.16M Buy
+15,500
New +$1.19M 0.02% 122

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Clal Insurance's EW Position: Q3 2024 in Review

Clal Insurance sold out of Edwards Lifesciences (EW) in Q3 2024, closing a stake of 9,000 shares — an estimated $831K sold.

Clal Insurance first reported a position in EW in Q4 2022 and held it in 3 quarters. The position peaked at $1.16M in Q4 2022. 1,194 funds tracked by Wall St. Rank hold EW as of Q3 2024.

  • Clal Insurance reported no remaining Edwards Lifesciences position as of Q3 2024 after selling out during the quarter.
  • Clal Insurance sold 9,000 Edwards Lifesciences shares in Q3 2024, an estimated $831K.
  • Clal Insurance first reported a position in Edwards Lifesciences in Q4 2022 and held it in 3 quarters.
  • Clal Insurance's Edwards Lifesciences position peaked at $1.16M in Q4 2022.
  • 1,194 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2024.

Based on Clal Insurance's 13F filing for Q3 2024, filed 12 Nov 2024.